333.04 Cr
2.42%
BSE Healthcare TRI
INF966L01CG3
5000.0
1000.0
1000
Mr. Sandeep Tandon
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - Growth Option - Regular Plan | 8.17 | - | - |
| Benchmark | - | - | - |
Equity
Debt
Others
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| TREPS 02-Mar-2026 DEPO 10 | 10.63 |
| SMS PHARMACEUTICALS LIMITED EQ NEW FV Re.1/- | 9.98 |
| ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/- | 9.25 |
| SEQUENT SCIENTIFIC LIMITED EQ NEW FV RS. 2/- | 9.05 |
| ASTER DM HEALTHCARE LIMITED EQ | 8.34 |
| Zydus Wellness Limited | 7.05 |
| PFIZER LIMITED EQ | 6.93 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 6.41 |
| ICICI PRUDENTIAL LIFE INSURANCE CO.LTD EQ | 5.56 |
| Aurobindo Pharma Limited | 5.36 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 61.25 |
| Financial Services | 10.21 |
| Fast Moving Consumer Goods | 7.05 |
| Consumer Services | 3.63 |
| Metals & Mining | 0.56 |